Authors:
Jones, SE
Missan, S
Zhabyeyev, P
McDonald, TF
Citation: Se. Jones et al., Selective phenylalkylamine block of I-Kr over other K+ currents in guinea-pig ventricular myocytes, BR J PHARM, 131(8), 2000, pp. 1809-1816
Authors:
Jones, SE
Shuba, LM
Zhabyeyev, P
McCullough, JR
McDonald, TF
Citation: Se. Jones et al., Differences in the effects of urinary incontinence agents S-oxybutynin andterodiline on cardiac K+ currents and action potentials, BR J PHARM, 131(2), 2000, pp. 245-254
Authors:
Ferguson, MW
Beaumont, PC
Jones, SE
Navaratnam, S
Parsons, BJ
Citation: Mw. Ferguson et al., Excited state and free radical properties of Rhodamine 123: a laser flash photolysis and radiolysis study, PCCP PHYS C, 1(2), 1999, pp. 261-268
Authors:
O'Shaughnessy, JA
Demers, LM
Jones, SE
Arseneau, J
Khandelwal, P
George, T
Gersh, R
Mauger, D
Manni, A
Citation: Ja. O'Shaughnessy et al., alpha-difluoromethylornithine as treatment for metastatic breast cancer patients, CLIN CANC R, 5(11), 1999, pp. 3438-3444
Citation: C. Elton et al., Initial experience of intramammary prostheses in breast conserving surgery. Elton C, Jones SE, Jones PA. Reply to Messrs Yelland, Rainsbury and Gazet, EUR J SUR O, 25(6), 1999, pp. 638-638
Authors:
Blum, JL
Jones, SE
Buzdar, AU
LoRusso, PM
Kuter, I
Vogel, C
Osterwalder, B
Burger, HU
Brown, CS
Griffin, T
Citation: Jl. Blum et al., Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer, J CL ONCOL, 17(2), 1999, pp. 485-493
Authors:
Jones, SE
Khandelwal, P
McIntyre, K
Mennel, R
Orr, D
Kirby, R
Agura, E
Duncan, L
Hyman, W
Roque, T
Regan, D
Schuster, M
Dimitrov, N
Garrison, L
Lange, M
Citation: Se. Jones et al., Randomized, double-blind, placebo-controlled trial to evaluate the hematopoietic growth factor PIXY321 after moderate-dose fluorouracil, doxorubicin,and cyclophosphamide in stage II and III breast cancer, J CL ONCOL, 17(10), 1999, pp. 3025-3032
Authors:
Holdaway, GP
Thorne, PD
Flatt, D
Jones, SE
Prandle, D
Citation: Gp. Holdaway et al., Comparison between ADCP and transmissometer measurements of suspended sediment concentration, CONT SHELF, 19(3), 1999, pp. 421-441
Authors:
Jomary, C
Thomas, M
Grist, J
Milbrandt, J
Neal, MJ
Jones, SE
Citation: C. Jomary et al., Expression patterns of neurturin and its receptor components in developingand degenerative mouse retina, INV OPHTH V, 40(3), 1999, pp. 568-574
Authors:
Shuba, LM
Kasamaki, Y
Jones, SE
Ogura, T
Mccullough, JR
Mcdonald, TF
Citation: Lm. Shuba et al., Action potentials, contraction, and membrane currents in guinea pig ventricular preparations treated with the antispasmodic agent terodiline, J PHARM EXP, 290(3), 1999, pp. 1417-1426
Authors:
Jomary, C
Darrow, RM
Wong, P
Organisciak, DT
Neal, MJ
Jones, SE
Citation: C. Jomary et al., Lack of causal relationship between clusterin expression and photoreceptorapoptosis in light-induced retinal degeneration, J NEUROCHEM, 72(5), 1999, pp. 1923-1929
Authors:
Jomary, C
Chatelain, G
Michel, D
Weston, A
Neal, MJ
Jones, SE
Citation: C. Jomary et al., Effect of targeted expression of clusterin in photoreceptor cells on retinal development and differentiation, J CELL SCI, 112(10), 1999, pp. 1455-1464
Authors:
Buzdar, AU
Jonat, W
Howell, A
Jones, SE
Blomqvist, CP
Vogel, CL
Citation: Au. Buzdar et al., Anastrozole versus megestrol acetate in the treatment of postmenopausal women with advanced breast carcinoma: results of a survival update based on acombined analysis of data from two mature phase III trials (vol 83, pg 1142, 1998), CANCER, 85(4), 1999, pp. 1010-1010
Authors:
Jones, SE
Jomary, C
Grist, J
Thomas, MR
Neal, MJ
Citation: Se. Jones et al., Expression of alpha B-crystallin in a mouse model of inherited retinal degeneration, NEUROREPORT, 9(18), 1998, pp. 4161-4165